Tuesday, October 18, 2016, Greensboro, N.C.:
Kepley BioSystems (KBI) was a finalist from among 3,500 original contestants, which narrowed to representatives of 500 deep-technology start-ups invited to participate in the third Hello Tomorrow Global Summit. The event took place last week on October 13-14, 2016, at the Le Centquatre conference center in Paris. The Global Summit, which Bloomberg News described as, “Where the brightest minds from the science-entrepreneurship ecosystem meet to build the future,” attracted the top global start-ups in an array of industries from Aeronautics to Food and Agriculture and everything in between.
Kepley BioSystems is pleased to announce that their National Science Foundation-funded synthetic crustacean bait helped place KBI in the top 1% of global start-ups in the Hello Tomorrow continuum. Start-up company competitors came from over 105 countries from around the world.
Over the two-day conference, KBI was able to present the dramatic equity potential for early capital in Kepley to elite investors and conference attendees. Among them were executives from sponsors that included Roche, Air Liquide, AIRBUS, L’Oreal, Carrefour and Michelin, along with Bloomberg News, The Boston Consulting Group and other global media and industry partners.
“The event was instructive and inspiring, including a keynote address by Michael Bloomberg, and as judged, we were among the top tier participants of science and technology entrepreneurs’ reinforcing our product mission,” said Dr. Anthony Dellinger, President of Kepley BioSystems.
Dr. Anthony L. Dellinger waits to discuss Kepley BioSystems synthetic crustacean bait, OrganoBait™ with members of Bloomberg News International in Paris, France, at the Hello Tomorrow Global Deep Technology start-up summit.
The Hello Tomorrow Challenge attracted 3,500 deep technology start-ups from 105 countries across the globe to compete at the Global Summit in Paris France on October 13-14, 2016.